NewsRoom Articles - Page 45 of 222

FridayJun 07, 2024 10:00 am

NIH Researchers Unveil AI Tool to Predict Oncology Patients’ Response to Immunotherapy

Scientists at the National Institutes of Health have designed an artificial intelligence (AI) tool that can predict if a patient’s cancer will respond to immune checkpoint inhibitors using clinical data. This artificial intelligence model may assist physicians in determining whether immunotherapy medications are effective in the treatment of different cancers. To determine the effectiveness of their machine-learning model, the researchers carried out a proof-of-concept study led by scientists from Memorial Sloan Kettering Cancer Center and the National Cancer Institute’s Center for Cancer Research. Their model was built and assessed using data from independent data sets, including more than 2,800 patients…

WednesdayJun 05, 2024 10:30 am

Astrotech Corp. (NASDAQ: ASTC) Subsidiary, “1st Detect”, Focuses on Superior Narcotics Trace Detection For Airport and Other Security Sites

Astrotech Corporation Subsidiary 1st Detect Approved as GSA Vendor; Introduces Advanced Narcotics Trace Detection Technology 1st Detect has now received approval from the U.S. General Services Administration (“GSA”) as an authorized vendor for government-related applications 1st Detect recently introduced a state-of-the-art Narcotics Trace Detection (“NTD”) narcotics library, which is particularly useful for detection at points of entry and government agencies involved in combating the illicit drug trade 1st Detect's portfolio now includes the TRACER 1000, Explosives Trace Detection (“ETD”) and Narcotics Trace detection Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. With recent…

WednesdayJun 05, 2024 10:00 am

How to Minimize E-Commerce Chargeback Losses

Merchants in e-commerce may benefit from learning how to minimize chargeback losses, especially as fraud is becoming more rampant. Chargeback refers to when money is returned to a customer after contesting a charge. Sometimes, customers may dispute the charge if they didn’t receive the product they wanted, but other times, they may do so to keep the product without having to part with their funds. Juniper Research 2023 projections show that losses incurred as a result of e-commerce fraud globally surpassed $48 billion. Additionally, a study by Kount, which surveyed its customers, determined that in 2021, companies incurred 2.3% revenue…

TuesdayJun 04, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use

Clene announced significant updates to their NIH-funded Accelerating Access to Critical Therapies Expanded Access Program (ACT-EAP) for CNM-Au8(R) compassionate use in amyotrophic lateral sclerosis (“ALS”) Clene has optimized its manufacturing, operational, and personnel processes to expand the program’s capacity to accommodate up to 180 participants The ACT-EAP, a collaboration among Clene, Columbia University, and Synapticure, was funded by the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS), signed into law by Congress and President Biden in December 2021 Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to improving mitochondrial health and protecting…

MondayJun 03, 2024 10:00 am

Virginia Tech Clinical Trial Seeks End to Brain Cancer Surgery

Patients with brain cancer often undergo surgery to treat the disease because this is the recommended treatment for this particular cancer. This doesn’t mean that surgery is always an option, as treatments for patients are often prescribed by their primary care providers. A trial conducted at the Virginia-Maryland College of Veterinary Medicine (Virginia Tech) looked into whether noninvasive treatments would do away with surgery in the management of brain cancer. For their study, the researchers used dogs to test out the effectiveness of focused ultrasound therapy, in particular histotripsy, in getting rid of brain tumors. Lauren Ruger, a postdoctoral research…

MondayJun 03, 2024 8:45 am

HealthLynked Corp. (HLYK) Continues to Expand AI Capabilities

HealthLynked is at the forefront of revolutionizing global healthcare related solutions for patients, doctors, and related healthcare organizations Some of the company’s solutions, including the HealthLynked Network, Augmented Real-Time Interface, and the new AI chat feature, incorporate artificial intelligence capabilities to foster better patient outcomes for all The new AI chat feature is designed to assist patients in locating healthcare providers across the country using markers such as name, specialty, or location and significantly enhance the effectiveness of the HealthLynked Concierge Team in reducing wait times and offering 24/7 service to users HealthLynked continues to lead in the development of…

FridayMay 31, 2024 10:00 am

Breakthrough Research Uncovers Benefits of Hidden Respiratory Disease Diagnosis

A recently conducted clinical trial has determined that treating individuals with undiagnosed chronic obstructive pulmonary disease or asthma improved their health and decreased healthcare visits for respiratory symptoms in the time they were diagnosed. To find individuals with the undiagnosed illnesses, the scientists dialed random numbers at different sites across Canada between 2017 and 2023. During the calls, respondents were asked whether there were any persons in the house who experienced unexplained prolonged coughs, wheezing or shortness of breath, or who were coughing up mucus. As a result of the calls, more than 26,000 individuals with these symptoms completed questionnaires.…

WednesdayMay 29, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA

PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration later this year for using suramin to treat Human African Trypanosomiasis PaxMedica is currently preparing for an associated and very important Type C meeting with the FDA scheduled for June 27th Type C meetings are designated by the FDA to address specific issues in drug development, such as clinical trial design, data requirements, or other scientific matters not covered by Type A or Type B meetings PaxMedica (NASDAQ: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, recently shared corporate updates regarding its continued…

WednesdayMay 29, 2024 10:00 am

Understanding Medigap vs. Medicare Advantage Plans

Medicare is a health insurance program that caters to aging persons at a fee. While the program provides a range of benefits and different types of coverage, it has its issues. To help with this, individuals should consider enrolling in a Medigap or Advantage plan. What is Medicare Advantage? Medicare Advantage, which is sometimes referred to as Part C, is offered by private insurers and is basically an individual’s primary insurance. It provides all benefits under Medicare as well as additional ones, including vision, dental, hearing and fitness coverage. Individuals eligible for the Advantage plan include younger individuals with disabilities,…

FridayMay 24, 2024 10:00 am

Study Discovers Elevated Risk of Toxicity Among Autistic Kids

In the last couple of decades, the number of individuals being diagnosed with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) has greatly increased. Researchers hypothesize that disorders such as ADHD and ASD are caused by a combination of environmental and genetic factors. One study found that there’s a difference in how kids with ADHD or autism eliminate bisphenol A from their bodies, in comparison to neurotypical kids. Bisphenol A (BPA) is a common plastic additive used in plastic production processes. It can also be found inside drink and food cans. Prior studies have also linked the plastic…